A novel defined TLR3 agonist as an effective vaccine adjuvant

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 52,006 followers.

A novel defined TLR3 agonist as an effective vaccine adjuvant https://t.co/gSdwBvrntH

11 Feb 2023

Reply Repost Favourite

A novel defined TLR3 agonist as an effective vaccine adjuvant https://t.co/F28jzZRlnZ https://t.co/V78JE8WuLl

24 Jan 2023

Reply Repost Favourite

New Research: A novel defined TLR3 agonist as an effective vaccine adjuvant: Synthetic double-stranded RNA analogs recognized by Toll-like receptor 3 (TLR3) are an attractive adjuvant candidate for vaccines, especially against intracellular… https://t.co/T

24 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.